224 related articles for article (PubMed ID: 35838758)
1. Innate immune cells and myelin profile in multiple sclerosis: a multi-tracer PET/MR study.
Pitombeira MS; Koole M; Campanholo KR; Souza AM; Duran FLS; Solla DJF; Mendes MF; Pereira SLA; Rimkus CM; Busatto GF; Callegaro D; Buchpiguel CA; de Paula Faria D
Eur J Nucl Med Mol Imaging; 2022 Nov; 49(13):4551-4566. PubMed ID: 35838758
[TBL] [Abstract][Full Text] [Related]
2. In Vivo Detection of Diffuse Inflammation in Secondary Progressive Multiple Sclerosis Using PET Imaging and the Radioligand ¹¹C-PK11195.
Rissanen E; Tuisku J; Rokka J; Paavilainen T; Parkkola R; Rinne JO; Airas L
J Nucl Med; 2014 Jun; 55(6):939-44. PubMed ID: 24711650
[TBL] [Abstract][Full Text] [Related]
3. Multimodal partial volume correction: Application to [
Grecchi E; Veronese M; Bodini B; García-Lorenzo D; Battaglini M; Stankoff B; Turkheimer FE
J Cereb Blood Flow Metab; 2017 Dec; 37(12):3803-3817. PubMed ID: 28569617
[TBL] [Abstract][Full Text] [Related]
4. Association of serum neurofilament light with microglial activation in multiple sclerosis.
Saraste M; Matilainen M; Vuorimaa A; Laaksonen S; Sucksdorff M; Leppert D; Kuhle J; Airas L
J Neurol Neurosurg Psychiatry; 2023 Sep; 94(9):698-706. PubMed ID: 37130728
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous assessment of blood flow and myelin content in the brain white matter with dynamic [11 C]PiB PET: a test-retest study in healthy controls.
Yazdan-Panah A; Bodini B; Soulier T; Veronese M; Bottlaender M; Tonietto M; Stankoff B
EJNMMI Res; 2024 May; 14(1):50. PubMed ID: 38801594
[TBL] [Abstract][Full Text] [Related]
6. Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis.
Sucksdorff M; Matilainen M; Tuisku J; Polvinen E; Vuorimaa A; Rokka J; Nylund M; Rissanen E; Airas L
Brain; 2020 Dec; 143(11):3318-3330. PubMed ID: 33006604
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195.
Kang Y; Schlyer D; Kaunzner UW; Kuceyeski A; Kothari PJ; Gauthier SA
PLoS One; 2018; 13(8):e0201289. PubMed ID: 30091993
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Non-Invasive Methods for (R)-[
Mantovani DBA; Pitombeira MS; Schuck PN; de Araújo AS; Buchpiguel CA; de Paula Faria D; M da Silva AM
J Imaging; 2024 Jan; 10(2):. PubMed ID: 38392087
[TBL] [Abstract][Full Text] [Related]
9. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
Herranz E; Giannì C; Louapre C; Treaba CA; Govindarajan ST; Ouellette R; Loggia ML; Sloane JA; Madigan N; Izquierdo-Garcia D; Ward N; Mangeat G; Granberg T; Klawiter EC; Catana C; Hooker JM; Taylor N; Ionete C; Kinkel RP; Mainero C
Ann Neurol; 2016 Nov; 80(5):776-790. PubMed ID: 27686563
[TBL] [Abstract][Full Text] [Related]
10. Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging.
Bezukladova S; Tuisku J; Matilainen M; Vuorimaa A; Nylund M; Smith S; Sucksdorff M; Mohammadian M; Saunavaara V; Laaksonen S; Rokka J; Rinne JO; Rissanen E; Airas L
Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32123046
[TBL] [Abstract][Full Text] [Related]
11. Translocator positron-emission tomography and magnetic resonance spectroscopic imaging of brain glial cell activation in multiple sclerosis.
Datta G; Violante IR; Scott G; Zimmerman K; Santos-Ribeiro A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Matthews PM
Mult Scler; 2017 Oct; 23(11):1469-1478. PubMed ID: 27903933
[TBL] [Abstract][Full Text] [Related]
12. Individual Mapping of Innate Immune Cell Activation Is a Candidate Marker of Patient-Specific Trajectories of Worsening Disability in Multiple Sclerosis.
Bodini B; Poirion E; Tonietto M; Benoit C; Palladino R; Maillart E; Portera E; Battaglini M; Bera G; Kuhnast B; Louapre C; Bottlaender M; Stankoff B
J Nucl Med; 2020 Jul; 61(7):1043-1049. PubMed ID: 32005777
[TBL] [Abstract][Full Text] [Related]
13. Early prognosticators of later TSPO-PET-measurable microglial activation in multiple sclerosis.
Laaksonen S; Saraste M; Sucksdorff M; Nylund M; Vuorimaa A; Matilainen M; Heikkinen J; Airas L
Mult Scler Relat Disord; 2023 Jul; 75():104755. PubMed ID: 37216883
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis.
Lehto J; Nylund M; Matilainen M; Sucksdorff M; Vuorimaa A; Rajander J; Wahlroos S; Hariri P; Airas L
Eur J Neurol; 2023 Aug; 30(8):2365-2375. PubMed ID: 37154404
[TBL] [Abstract][Full Text] [Related]
15. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
Wen J; Yablonskiy DA; Luo J; Lancia S; Hildebolt C; Cross AH
Neuroimage Clin; 2015; 9():164-75. PubMed ID: 27330979
[TBL] [Abstract][Full Text] [Related]
16. Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB.
Auvity S; Tonietto M; Caillé F; Bodini B; Bottlaender M; Tournier N; Kuhnast B; Stankoff B
Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):490-501. PubMed ID: 31686177
[TBL] [Abstract][Full Text] [Related]
17. Innate Immune Cell-Related Pathology in the Thalamus Signals a Risk for Disability Progression in Multiple Sclerosis.
Misin O; Matilainen M; Nylund M; Honkonen E; Rissanen E; Sucksdorff M; Airas L
Neurol Neuroimmunol Neuroinflamm; 2022 Jul; 9(4):. PubMed ID: 35581004
[TBL] [Abstract][Full Text] [Related]
18. In vivo TSPO imaging in patients with multiple sclerosis: a brain PET study with [18F]FEDAA1106.
Takano A; Piehl F; Hillert J; Varrone A; Nag S; Gulyás B; Stenkrona P; Villemagne VL; Rowe CC; Macdonell R; Tawil NA; Kucinski T; Zimmermann T; Schultze-Mosgau M; Thiele A; Hoffmann A; Halldin C
EJNMMI Res; 2013 Apr; 3(1):30. PubMed ID: 23618062
[TBL] [Abstract][Full Text] [Related]
19. Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET.
Nylund M; Sucksdorff M; Matilainen M; Polvinen E; Tuisku J; Airas L
Brain Commun; 2022 Feb; 4(1):fcab301. PubMed ID: 34993478
[TBL] [Abstract][Full Text] [Related]
20. Predicting PET-derived myelin content from multisequence MRI for individual longitudinal analysis in multiple sclerosis.
Wei W; Poirion E; Bodini B; Tonietto M; Durrleman S; Colliot O; Stankoff B; Ayache N
Neuroimage; 2020 Dec; 223():117308. PubMed ID: 32889117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
